These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7862157)

  • 21. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias.
    Tanaka T; Mitani K; Kurokawa M; Ogawa S; Tanaka K; Nishida J; Yazaki Y; Shibata Y; Hirai H
    Mol Cell Biol; 1995 May; 15(5):2383-92. PubMed ID: 7739522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide.
    Sakakura C; Yamaguchi-Iwai Y; Satake M; Bae SC; Takahashi A; Ogawa E; Hagiwara A; Takahashi T; Murakami A; Makino K
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11723-7. PubMed ID: 7972130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia.
    Miyoshi H; Ohira M; Shimizu K; Mitani K; Hirai H; Imai T; Yokoyama K; Soeda E; Ohki M
    Nucleic Acids Res; 1995 Jul; 23(14):2762-9. PubMed ID: 7651838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1.
    Nucifora G; Begy CR; Erickson P; Drabkin HA; Rowley JD
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7784-8. PubMed ID: 8395054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells.
    Hayashi K; Natsume W; Watanabe T; Abe N; Iwai N; Okada H; Ito Y; Asano M; Iwakura Y; Habu S; Takahama Y; Satake M
    J Immunol; 2000 Dec; 165(12):6816-24. PubMed ID: 11120804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AML1 and Pebp2: the gene for a transcription factor is involved in recurring translocations in human acute myeloid leukemia.
    Rowley JD
    Jpn J Cancer Res; 1994 Dec; 85(12):inside front cover. PubMed ID: 7852178
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular basis of the t(8;21) translocation in acute myeloid leukaemia.
    Ohki M
    Semin Cancer Biol; 1993 Dec; 4(6):369-75. PubMed ID: 8142622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.
    Miyamoto T; Nagafuji K; Akashi K; Harada M; Kyo T; Akashi T; Takenaka K; Mizuno S; Gondo H; Okamura T; Dohy H; Niho Y
    Blood; 1996 Jun; 87(11):4789-96. PubMed ID: 8639850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript.
    Miyoshi H; Kozu T; Shimizu K; Enomoto K; Maseki N; Kaneko Y; Kamada N; Ohki M
    EMBO J; 1993 Jul; 12(7):2715-21. PubMed ID: 8334990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.
    Kurokawa M; Tanaka T; Tanaka K; Ogawa S; Mitani K; Yazaki Y; Hirai H
    Oncogene; 1996 Feb; 12(4):883-92. PubMed ID: 8632911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.
    Fears S; Mathieu C; Zeleznik-Le N; Huang S; Rowley JD; Nucifora G
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1642-7. PubMed ID: 8643684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of AML1 and ETO Transcripts in hematopoietic cells.
    Era T; Asou N; Yamaguchi K; Yamasaki H; Kamada N; Nishikawa S; Takatsuki K
    Leukemia; 1995 Oct; 9 Suppl 1():S26-8. PubMed ID: 7475308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lineage- and stage-specific expression of runt box polypeptides in primitive and definitive hematopoiesis.
    Corsetti MT; Calabi F
    Blood; 1997 Apr; 89(7):2359-68. PubMed ID: 9116279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation.
    Kanno Y; Kanno T; Sakakura C; Bae SC; Ito Y
    Mol Cell Biol; 1998 Jul; 18(7):4252-61. PubMed ID: 9632809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the human genomic structure of the Runt domain-encoding PEBP2/CBFalpha gene family.
    Ahn MY; Bae SC; Maruyama M; Ito Y
    Gene; 1996 Feb; 168(2):279-80. PubMed ID: 8654962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor.
    Niki M; Okada H; Takano H; Kuno J; Tani K; Hibino H; Asano S; Ito Y; Satake M; Noda T
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5697-702. PubMed ID: 9159135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The runt protein and its companion PEBP2: a close link between this transcription factor and AML.
    Ito Y
    Leukemia; 1997 Apr; 11 Suppl 3():279-80. PubMed ID: 9209364
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential expression of subspecies of polyomavirus and murine leukemia virus enhancer core binding protein, PEBP2, in various hematopoietic cells.
    Satake M; Inuzuka M; Shigesada K; Oikawa T; Ito Y
    Jpn J Cancer Res; 1992 Jul; 83(7):714-22. PubMed ID: 1325429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells.
    Era T; Asou N; Kunisada T; Yamasaki H; Asou H; Kamada N; Nishikawa S; Yamaguchi K; Takatsuki K
    Genes Chromosomes Cancer; 1995 May; 13(1):25-33. PubMed ID: 7541640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.